GS
GTS Securities’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683K | Buy |
40,744
+23,585
| +137% | +$395K | 0.03% | 522 |
|
|
2025
Q1 | $264K | Buy |
+17,159
| New | +$264K | 0.01% | 1014 |
|
|
2024
Q4 | – | Sell |
-379,668
| Closed | -$6.84M | – | 2105 |
|
|
2024
Q3 | $6.84M | Buy |
379,668
+988
| +0.3% | +$17.8K | 0.01% | 123 |
|
|
2024
Q2 | $6.15M | Sell |
378,680
-647,180
| -63% | -$10.5M | 0.01% | 151 |
|
|
2024
Q1 | $14.5M | Buy |
1,025,860
+276,106
| +37% | +$3.9M | 0.03% | 43 |
|
|
2023
Q4 | $7.83M | Buy |
749,754
+16,409
| +2% | +$171K | 0.01% | 110 |
|
|
2023
Q3 | $7.48M | Sell |
733,345
-19,364
| -3% | -$198K | 0.01% | 118 |
|
|
2023
Q2 | $5.67M | Buy |
+752,709
| New | +$5.67M | 0.18% | 117 |
|